Literature DB >> 24990401

Metabolic parameters using ¹⁸F-FDG PET/CT correlate with occult lymph node metastasis in squamous cell lung carcinoma.

Do-Hoon Kim1, Bong-Il Song, Chae Moon Hong, Shin Young Jeong, Sang-Woo Lee, Jaetae Lee, Byeong-Cheol Ahn.   

Abstract

PURPOSE: The aim of this study was to investigate predictability of occult lymph node metastasis (OLM) using metabolic parameters on pretreatment (18)F-fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET)/CT in squamous cell non-small cell lung carcinoma (SC-NSCLC) patients who were clinically node negative (cN0) before surgery.
METHODS: A total of 63 cN0 SC-NSCLC patients (M/F = 61/2, mean age 64.1 ± 8.0) who underwent curative surgery with lymph node dissection were enrolled in this study. Metabolic tumor volume (MTV) of the primary tumor was obtained with a standardized uptake value (SUV) threshold of 2.5. Total lesion glycolysis (TLG) was calculated by multiplication of the MTV and its SUVmean. Metabolic parameters (SUVmax, MTV, and TLG) and clinicopathological factors were analyzed for OLM.
RESULTS: Of 63 patients, 12 (19.0 %) had OLM. Significantly higher SUVmax, MTV, TLG, and pathological tumor size were observed in patients with OLM. The optimal cutoff values for prediction of OLM determined using a receiver-operating characteristic (ROC) curve were 8.8 for SUVmax, 18.9 cm(3) for MTV, 88.4 for TLG, and 2.8 cm for pathological tumor size. Univariate analysis showed correlation of SUVmax, MTV, and TLG with the rate of OLM. In multivariate analyses, high SUVmax and MTV showed an association with an increased risk of OLM, after adjusting for age, sex, pathological tumor size, T stage, and location.
CONCLUSION: Metabolic parameters on pretreatment (18)F-FDG PET/CT were significant predictors for OLM in cN0 SC-NSCLC patients. Surgical planning can be tailored based on the parameters in order to reduce the risk of hidden residual lymph node metastases in patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24990401     DOI: 10.1007/s00259-014-2831-6

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  21 in total

1.  Video-assisted thoracic surgery lobectomy: 3-year initial experience with 200 cases.

Authors:  Diego Gonzalez; Mercedes de la Torre; Marina Paradela; Ricardo Fernandez; Maria Delgado; Jose Garcia; Eva Fieira; Lucia Mendez
Journal:  Eur J Cardiothorac Surg       Date:  2011-03-31       Impact factor: 4.191

2.  Occult nodal metastasis in patients with non-small cell lung cancer at clinical stage IA by PET/CT.

Authors:  Hye Kyeong Park; Kyeongman Jeon; Won-Jung Koh; Gee Young Suh; Hojoong Kim; O Jung Kwon; Man Pyo Chung; Kyung Soo Lee; Young Mog Shim; Joungho Han; Sang-Won Um
Journal:  Respirology       Date:  2010-11       Impact factor: 6.424

3.  Impact of the definition of peak standardized uptake value on quantification of treatment response.

Authors:  Matt Vanderhoek; Scott B Perlman; Robert Jeraj
Journal:  J Nucl Med       Date:  2012-01       Impact factor: 10.057

4.  Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.

Authors:  Sung Shine Shim; Kyung Soo Lee; Byung-Tae Kim; Myung Jin Chung; Eun Jung Lee; Joungho Han; Joon Young Choi; O Jung Kwon; Young Mog Shim; Seonwoo Kim
Journal:  Radiology       Date:  2005-07-12       Impact factor: 11.105

5.  Metabolic Tumor Volume Measured by F-18 FDG PET/CT can Further Stratify the Prognosis of Patients with Stage IV Non-Small Cell Lung Cancer.

Authors:  Su Woong Yoo; Jahae Kim; Ari Chong; Seong-Young Kwon; Jung-Joon Min; Ho-Chun Song; Hee-Seung Bom
Journal:  Nucl Med Mol Imaging       Date:  2012-09-05

6.  Occult metastases in lymph nodes predict survival in resectable non-small-cell lung cancer: report of the ACOSOG Z0040 trial.

Authors:  Valerie W Rusch; Debra Hawes; Paul A Decker; Sue Ellen Martin; Andrea Abati; Rodney J Landreneau; G Alexander Patterson; Richard I Inculet; David R Jones; Richard A Malthaner; Robbin G Cohen; Karla Ballman; Joe B Putnam; Richard J Cote
Journal:  J Clin Oncol       Date:  2011-10-11       Impact factor: 44.544

7.  Prediction for recurrence using F-18 FDG PET/CT in pathologic N0 lung adenocarcinoma after curative surgery.

Authors:  Do-Hoon Kim; Seung Hyun Son; Choon-Young Kim; Chae Moon Hong; Jong-Ryool Oh; Bong-Il Song; Hae Won Kim; Shin Young Jeong; Sang-Woo Lee; Jaetae Lee; Byeong-Cheol Ahn
Journal:  Ann Surg Oncol       Date:  2013-09-18       Impact factor: 5.344

8.  Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study.

Authors:  Ronald Boellaard; Nanda C Krak; Otto S Hoekstra; Adriaan A Lammertsma
Journal:  J Nucl Med       Date:  2004-09       Impact factor: 10.057

9.  Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.

Authors:  Didier Lardinois; Walter Weder; Thomas F Hany; Ehab M Kamel; Stephan Korom; Burkhardt Seifert; Gustav K von Schulthess; Hans C Steinert
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

10.  Risk factors for predicting the occult nodal metastasis in T1-2N0M0 NSCLC patients staged by PET/CT: potential value in the clinic.

Authors:  Ling Li; Shuhua Ren; Yingjian Zhang; Yihui Guan; Jun Zhao; Jun Liu; Qun Wang; Gang Chen; Haiquan Chen; Jiaqing Xiang; Xiaolong Fu
Journal:  Lung Cancer       Date:  2013-05-09       Impact factor: 5.705

View more
  15 in total

1.  A SUVmax-based propensity matched analysis of stereotactic body radiotherapy versus surgery in stage I non-small cell lung cancer: unveiling the role of 18F-FDG PET/CT in clinical decision-making.

Authors:  L Ye; F Xu; S Shi; Z Zeng; X Jin; Y Huang; C Lu; J Gu; D Ge; J He
Journal:  Clin Transl Oncol       Date:  2018-01-11       Impact factor: 3.405

2.  New PET/CT criterion for nodal staging in non-small cell lung cancer: measurement of the ratio of section area of standard uptake values ≥2.5/lymph node section area.

Authors:  Yoshitaro Saito; Kazuhiro Imai; Koichi Ishiyama; Hajime Saito; Satoru Motoyama; Yusuke Sato; Hayato Konno; Satoshi Fujishima; Manabu Hashimoto; Yoshihiro Minamiya
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-02-23

3.  18F-FDG PET/CT and circulating tumor cells in treatment-naive patients with non-small-cell lung cancer.

Authors:  Fengxian Zhang; Xiaodong Wu; Junjie Zhu; Yan Huang; Xiao Song; Lei Jiang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-02-25       Impact factor: 9.236

4.  18F-FDG PET/CT radiomics nomogram for predicting occult lymph node metastasis of non-small cell lung cancer.

Authors:  Jianyi Qiao; Xin Zhang; Ming Du; Pengyuan Wang; Jun Xin
Journal:  Front Oncol       Date:  2022-09-28       Impact factor: 5.738

5.  Minor components of micropapillary and solid subtypes in lung invasive adenocarcinoma (≤ 3 cm): PET/CT findings and correlations with lymph node metastasis.

Authors:  Cheng Chang; Xiaoyan Sun; Wenlu Zhao; Rui Wang; Xiaohua Qian; Bei Lei; Lihua Wang; Liu Liu; Maomei Ruan; Wenhui Xie; Junkang Shen
Journal:  Radiol Med       Date:  2019-12-10       Impact factor: 3.469

6.  Prediction of occult lymph node metastasis using volume-based PET parameters in small-sized peripheral non-small cell lung cancer.

Authors:  Seong Yong Park; Joon-Kee Yoon; Kwang Joo Park; Su Jin Lee
Journal:  Cancer Imaging       Date:  2015-12-22       Impact factor: 3.909

7.  Prognostic value of intratumoral metabolic heterogeneity on F-18 fluorodeoxyglucose positron emission tomography/computed tomography in locally advanced cervical cancer patients treated with concurrent chemoradiotherapy.

Authors:  Gun Oh Chong; Won Kee Lee; Shin Young Jeong; Shin-Hyung Park; Yoon Hee Lee; Sang-Woo Lee; Dae Gy Hong; Jae-Chul Kim; Yoon Soon Lee
Journal:  Oncotarget       Date:  2017-06-28

8.  Pre-Operative Prediction of Mediastinal Node Metastasis Using Radiomics Model Based on 18F-FDG PET/CT of the Primary Tumor in Non-Small Cell Lung Cancer Patients.

Authors:  Kai Zheng; Xinrong Wang; Chengzhi Jiang; Yongxiang Tang; Zhihui Fang; Jiale Hou; Zehua Zhu; Shuo Hu
Journal:  Front Med (Lausanne)       Date:  2021-06-18

9.  Preoperative Prediction of Cervical Lymph Node Metastasis Using Primary Tumor SUVmax on 18F-FDG PET/CT in Patients with Papillary Thyroid Carcinoma.

Authors:  Ji-hoon Jung; Choon-Young Kim; Seung Hyun Son; Do-Hoon Kim; Shin Young Jeong; Sang-Woo Lee; Jaetae Lee; Byeong-Cheol Ahn
Journal:  PLoS One       Date:  2015-12-04       Impact factor: 3.240

10.  Maximum Standardized Uptake Value (SUVmax) of Primary Tumor Predicts Occult Neck Metastasis in Oral Cancer.

Authors:  Grégoire B Morand; Domenic G Vital; Ken Kudura; Jonas Werner; Sandro J Stoeckli; Gerhard F Huber; Martin W Huellner
Journal:  Sci Rep       Date:  2018-08-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.